Allogeneic pancreatic islet cell transplantation for type 1 diabetes mellitus

This guidance requires that clinicians or units undertaking the procedure for the first time make special arrangements for audit. NICE has identified relevant audit criteria and developed an audit tool (which is for use at local discretion).

NICE has issued guidelines on type 1 diabetes in adults, diabetes (type 1 and type 2) in children and young people and diabetic foot problems. NICE has also issued technology appraisal guidance on continuous subcutaneous insulin infusion for the treatment of diabetes mellitus. NICE has published HealthTech guidance on autologous pancreatic islet cell transplantation for improved glycaemic control after pancreatectomy.